OTC Cold and Cough Medicines Market

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. The drugs for the treatment of cold and cough acts on the receptors to which the virus causing the infection gets attached to, by antagonizing the action of the receptors and killing the viral infection, thereby reducing congestion by lysing the mucus and dilating the bronchioles constricted by the mucus deposition. Cold weather is not directly associated with common cold, but the virus which causes common cold, called rhinovirus, is responsible for all cold related illnesses. Once the virus is inhaled, it attaches to the cells in nasal passages.
OTC Cold and Cough Medicines Market aims to provide a comprehensive presentation of the global market for OTC Cold and Cough Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Cold and Cough Medicines. OTC Cold and Cough Medicines Market contains market size and forecasts of OTC Cold and Cough Medicines in global, including the following market information:
Global OTC Cold and Cough Medicines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global OTC Cold and Cough Medicines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five OTC Cold and Cough Medicines companies in 2022 (%)
The global OTC Cold and Cough Medicines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pellets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of OTC Cold and Cough Medicines include Sanofi-Aventis, Johnson & Johnson, Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZeneca Plc., Pfizer Inc., Sun Pharmaceutical and Prestige Brands Holdings, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the OTC Cold and Cough Medicines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OTC Cold and Cough Medicines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global OTC Cold and Cough Medicines Market Segment Percentages, by Type, 2022 (%)
Pellets
Drops
Tablets
Capsules
Powders
Sprays
Global OTC Cold and Cough Medicines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global OTC Cold and Cough Medicines Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global OTC Cold and Cough Medicines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global OTC Cold and Cough Medicines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OTC Cold and Cough Medicines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies OTC Cold and Cough Medicines revenues share in global market, 2022 (%)
Key companies OTC Cold and Cough Medicines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies OTC Cold and Cough Medicines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Johnson & Johnson
Reckitt Benckiser Group Plc.
Novartis AG
GlaxoSmithKline Plc.
AstraZeneca Plc.
Pfizer Inc.
Sun Pharmaceutical
Prestige Brands Holdings, Inc.
Procter & Gamble Co.
Outline of Major Chapters:
Chapter 1: Introduces the definition of OTC Cold and Cough Medicines, market overview.
Chapter 2: Global OTC Cold and Cough Medicines market size in revenue and volume.
Chapter 3: Detailed analysis of OTC Cold and Cough Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OTC Cold and Cough Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global OTC Cold and Cough Medicines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.